Are Vaxfab Enterprises Ltd latest results good or bad?

Feb 14 2026 07:59 PM IST
share
Share Via
Vaxfab Enterprises Ltd's latest results show strong revenue growth with net sales reaching ₹69.61 crores, but the company reported a net loss of ₹2.25 crores in Q2 FY26, indicating profitability challenges despite a significant increase in scale. Investors should watch future quarters for sustainability in growth and profitability.
Vaxfab Enterprises Ltd's latest financial results indicate a complex operational landscape characterized by significant revenue growth alongside challenges in profitability. In the first half of FY26, the company reported net sales of ₹69.61 crores, marking a record high for the firm. However, this revenue surge was accompanied by a consolidated net loss of ₹2.25 crores in Q2 FY26, representing a notable shift from previous profitable quarters.
The financial performance illustrates a dramatic transformation in scale, with net sales for Q1 FY23 at just ₹4.15 crores, contrasting sharply with the current figures. The volatility in profitability is evident, as the company has experienced substantial fluctuations in operating margins, which have ranged from 2.09% to 30.77% in recent quarters. This inconsistency raises questions about the company's ability to manage costs and sustain its business model effectively. Moreover, the return on capital employed (ROCE) for H1 FY26 stood at 35.14%, reflecting a significant improvement compared to historical averages, although the average ROCE remains concerning at -41.34%. The balance sheet shows no long-term debt, which is a positive aspect, but current liabilities have increased, indicating potential pressures in working capital management. The stock has exhibited high volatility, with a one-year return of 323.03%, significantly outperforming the broader market. However, this performance comes with risks, as the stock's volatility is markedly higher than the market average, suggesting speculative trading behavior rather than a stable investment. Overall, Vaxfab Enterprises Ltd's recent results highlight a company in transition, achieving remarkable revenue growth while grappling with profitability challenges. The company saw an adjustment in its evaluation, reflecting the mixed operational trends observed in its financial performance. Investors should closely monitor the upcoming quarters to assess the sustainability of its growth and profitability trajectory.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News